These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6143342)

  • 1. A novel chemically induced animal model of human anxiety.
    Skolnick P; Ninan P; Insel T; Crawley J; Paul S
    Psychopathology; 1984; 17 Suppl 1():25-36. PubMed ID: 6143342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications.
    Insel TR; Ninan PT; Aloi J; Jimerson DC; Skolnick P; Paul SM
    Arch Gen Psychiatry; 1984 Aug; 41(8):741-50. PubMed ID: 6331336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeys.
    Crawley JN; Ninan PT; Pickar D; Chrousos GP; Linnoila M; Skolnick P; Paul SM
    J Neurosci; 1985 Feb; 5(2):477-85. PubMed ID: 2983041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine receptor-mediated experimental "anxiety" in primates.
    Ninan PT; Insel TM; Cohen RM; Cook JM; Skolnick P; Paul SM
    Science; 1982 Dec; 218(4579):1332-4. PubMed ID: 6293059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative and aversive properties of beta-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys.
    Takada K; Winger G; Cook J; Larscheid P; Woods JH
    Life Sci; 1986 Mar; 38(11):1049-56. PubMed ID: 3005790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of ethyl-beta-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxiety.
    File SE; Lister RG
    Neurosci Lett; 1983 Aug; 39(1):91-4. PubMed ID: 6314195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Carboline-induced anxiety states.
    Skolnick P; Crawley JN; Glowa JR; Paul SM
    Psychopathology; 1984; 17 Suppl 3():52-60. PubMed ID: 6505120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural and molecular mechanisms in anxiety.
    Wolkowitz OM; Paul SM
    Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral studies with anxiolytic drugs. II. Interactions of zopiclone with ethyl-beta-carboline-3-carboxylate and Ro 15-1788 in squirrel monkeys.
    Barrett JE; Brady LS; Stanley JA; Mansbach RS; Witkin JM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):313-9. PubMed ID: 2868115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects induced by beta CCE in free or restrained rhesus monkeys (Macaca mulatta).
    Lagarde D; Laurent J; Milhaud C; Andre E; Aubin HJ; Anton G
    Pharmacol Biochem Behav; 1990 Mar; 35(3):713-9. PubMed ID: 2339160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-carboline on fear-related behavioral and neurohormonal responses in infant rhesus monkeys.
    Kalin NH; Shelton SE; Turner JG
    Biol Psychiatry; 1992 May; 31(10):1008-19. PubMed ID: 1324744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearing paradigm in a nonhuman primate affects response to beta-CCE challenge.
    Insel TR; Scanlan J; Champoux M; Suomi SJ
    Psychopharmacology (Berl); 1988; 96(1):81-6. PubMed ID: 3147480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative GABA(A) modulators attenuate the discriminative stimulus effects of benzodiazepines and the neuroactive steroid pregnanolone in rhesus monkeys.
    McMahon LR; France CP
    Psychopharmacology (Berl); 2005 Oct; 181(4):697-705. PubMed ID: 15983789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of beta-carbolines in conscious rats.
    Wible JH; Luft FC; Stock D; DiMicco JA
    Hypertens Res; 1996 Sep; 19(3):161-70. PubMed ID: 8891744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman primate studies of fear, anxiety, and temperament and the role of benzodiazepine receptors and GABA systems.
    Kalin NH
    J Clin Psychiatry; 2003; 64 Suppl 3():41-4. PubMed ID: 12662133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central benzodiazepine involvement in clonidine cardiovascular actions.
    Castro JL; Ricci D; Taira CA; Ramirez A
    Can J Physiol Pharmacol; 1999 Nov; 77(11):844-51. PubMed ID: 10593656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in the neurobiology of anxiety.
    Skolnick P; Paul SM
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):12-20. PubMed ID: 6315689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of the beta-carboline derivatives ZK 93423 and ZK 91296 in squirrel monkeys: comparison with lorazepam and suriclone.
    Wettstein JG; Spealman RD
    J Pharmacol Exp Ther; 1987 Feb; 240(2):471-5. PubMed ID: 2879907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional modulation of cerebral gamma-aminobutyric acidA receptor/benzodiazepine receptor/chloride ion channel complex with ethyl beta-carboline-3-carboxylate: presence of independent binding site for ethyl beta-carboline-3-carboxylate.
    Taguchi J; Kuriyama K
    J Pharmacol Exp Ther; 1990 May; 253(2):558-66. PubMed ID: 2159999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.